|
Index of reports
> Cases resulting in life threatening events (13)
Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in life threatening events.
Adverse event in 24 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a individual with unspecified qualification from United States on 2007-10-23
Patient: 24 year old female
Adverse reactions / side effects: Botulism
Adverse event resulted in: life threatening event
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-19
Patient: female
Adverse reactions / side effects: Endocarditis Bacterial, Bacteraemia, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-17
Patient: female
Adverse reactions / side effects: Sepsis, Endocarditis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-07-30
Patient: female
Adverse reactions / side effects: Dysphagia, Hepatic Failure, Rash
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Canada on 2007-06-04
Patient: male, weighing 73.9 kg (162.6 pounds)
Adverse reactions / side effects: Grand MAL Convulsion, Coma, Acute Respiratory Distress Syndrome, Ventricular Fibrillation, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Lamotrigine; Wellbutrin
Adverse event in 60 year old male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-05-31
Patient: 60 year old male, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Dyspnoea, Dysphagia, Paralysis, Vocal Cord Paralysis, Headache, Botulism, Speech Disorder, Muscle Strain, Fatigue, Dysphonia, Oesophageal Disorder, Heart Rate Increased, Vasodilatation, Tracheal Disorder, Asthenia
Adverse event resulted in: life threatening event
Suspect drug(s):
Botox
Dosage: 400 units one time im
Indication: Muscle Spasms
Start date: 2007-02-06
End date: 2007-02-06
Botox
Dosage: 400 units one time im
Indication: Musculoskeletal Pain
Start date: 2007-02-06
End date: 2007-02-06
Botox
Dosage: 400 units one time im
Indication: Neck Pain
Start date: 2007-02-06
End date: 2007-02-06
Adverse event in receiving Botox (Botulinum Toxin Type A)
Reported by a pharmacist from United States on 2007-05-21
Patient:
Adverse reactions / side effects: Therapeutic Product Contamination, Pharmaceutical Product Complaint, Botulism
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a pharmacist from United States on 2007-05-18
Patient: female
Adverse reactions / side effects: Lung Disorder, Carbon Dioxide Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Canada on 2007-05-08
Patient: male
Adverse reactions / side effects: Grand MAL Convulsion, Coma, Acute Respiratory Distress Syndrome, Ventricular Fibrillation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Lamotrigine; Wellbutrin
Adverse event in 3 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-03-06
Patient: 3 year old female, weighing 5.4 kg (11.8 pounds)
Adverse reactions / side effects: Weight Decreased, Drooling, Dysphagia, Aspiration, Apnoea, Asthenia
Adverse event resulted in: life threatening event
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-02-20
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /; Diane
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-01-23
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Guillain-Barre Syndrome, Cytomegalovirus Infection, Muscle Spasms, Organ Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-01-16
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Death, Guillain-Barre Syndrome, Muscle Spasms
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /
|
